What is a stock summary page? Click here for an overview.
Business Description
Novolog (pharm-up 1966) Ltd
ISIN : IL0011401515
Compare
Compare
Traded in other countries / regions
NVLG.Israel IPO Date
2017-02-28Description
Novolog (pharm-up 1966) Ltd is an Israeli public health care company. The company operates in four divisions: The digital division, Health Division, The logistics division and International health services.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.25 | |||||
Equity-to-Asset | 0.12 | |||||
Debt-to-Equity | 0.54 | |||||
Debt-to-EBITDA | 1.33 | |||||
Interest Coverage | 5.4 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 0.88 | |||||
Beneish M-Score | -2.4 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 17.5 | |||||
3-Year EBITDA Growth Rate | 9.2 | |||||
3-Year EPS without NRI Growth Rate | -4.2 | |||||
3-Year FCF Growth Rate | 24.1 | |||||
3-Year Book Growth Rate | -7.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 58.81 | |||||
9-Day RSI | 49.68 | |||||
14-Day RSI | 46.66 | |||||
3-1 Month Momentum % | -15.25 | |||||
6-1 Month Momentum % | 10.03 | |||||
12-1 Month Momentum % | 5.39 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.96 | |||||
Quick Ratio | 0.83 | |||||
Cash Ratio | 0.1 | |||||
Days Inventory | 53.8 | |||||
Days Sales Outstanding | 304.23 | |||||
Days Payable | 421.91 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 3.17 | |||||
Dividend Payout Ratio | 0.99 | |||||
3-Year Dividend Growth Rate | 7.4 | |||||
Forward Dividend Yield % | 5.08 | |||||
5-Year Yield-on-Cost % | 5.37 | |||||
3-Year Average Share Buyback Ratio | -3.3 | |||||
Shareholder Yield % | 3.93 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 8.94 | |||||
Operating Margin % | 3.46 | |||||
Net Margin % | 1.9 | |||||
FCF Margin % | 4.94 | |||||
ROE % | 10.28 | |||||
ROA % | 1.31 | |||||
ROIC % | 6.97 | |||||
3-Year ROIIC % | -0.92 | |||||
ROC (Joel Greenblatt) % | 23 | |||||
ROCE % | 12.03 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 19.09 | |||||
PE Ratio without NRI | 19.09 | |||||
Shiller PE Ratio | 21.47 | |||||
Price-to-Owner-Earnings | 7.19 | |||||
PEG Ratio | 2.12 | |||||
PS Ratio | 0.38 | |||||
PB Ratio | 2.09 | |||||
Price-to-Tangible-Book | 15.42 | |||||
Price-to-Free-Cash-Flow | 7.74 | |||||
Price-to-Operating-Cash-Flow | 4.85 | |||||
EV-to-EBIT | 10.59 | |||||
EV-to-EBITDA | 5.02 | |||||
EV-to-Revenue | 0.37 | |||||
EV-to-FCF | 7.19 | |||||
Price-to-GF-Value | 0.64 | |||||
Price-to-Projected-FCF | 0.63 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.03 | |||||
Price-to-Graham-Number | 3.59 | |||||
Earnings Yield (Greenblatt) % | 9.44 | |||||
FCF Yield % | 12.67 | |||||
Forward Rate of Return (Yacktman) % | 18.02 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Novolog (pharm-up 1966) Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₪) | 2,021.602 | ||
EPS (TTM) (₪) | 0.079 | ||
Beta | - | ||
3-Year Sharpe Ratio | -0.63 | ||
3-Year Sortino Ratio | -0.76 | ||
Volatility % | 26.85 | ||
14-Day RSI | 46.66 | ||
14-Day ATR (₪) | 0.056196 | ||
20-Day SMA (₪) | 1.5611 | ||
12-1 Month Momentum % | 5.39 | ||
52-Week Range (₪) | 1.35 - 1.96 | ||
Shares Outstanding (Mil) | 510.84 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Novolog (pharm-up 1966) Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Novolog (pharm-up 1966) Ltd Stock Events
Event | Date | Price (₪) | ||
---|---|---|---|---|
No Event Data |
Novolog (pharm-up 1966) Ltd Frequently Asked Questions
What is Novolog (pharm-up 1966) Ltd(XTAE:NVLG)'s stock price today?
The current price of XTAE:NVLG is ₪1.57. The 52 week high of XTAE:NVLG is ₪1.96 and 52 week low is ₪1.35.
When is next earnings date of Novolog (pharm-up 1966) Ltd(XTAE:NVLG)?
The next earnings date of Novolog (pharm-up 1966) Ltd(XTAE:NVLG) is .
Does Novolog (pharm-up 1966) Ltd(XTAE:NVLG) pay dividends? If so, how much?
The Dividend Yield %  of Novolog (pharm-up 1966) Ltd(XTAE:NVLG) is 3.17% (As of Today), Highest Dividend Payout Ratio of Novolog (pharm-up 1966) Ltd(XTAE:NVLG) was 1.72. The lowest was 0.33. And the median was 0.71. The  Forward Dividend Yield % of Novolog (pharm-up 1966) Ltd(XTAE:NVLG) is 5.08%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |